Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tongling Jieya Biologic Technology
301108
5
XI'AN WONDER
836419
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -34.80%2.75B | -52.19%2.28B | -29.72%3.62B | -33.31%3.92B | -28.62%4.22B | -26.24%4.78B | -34.05%5.16B | 129.48%5.88B | --5.92B | 148.26%6.48B |
Transactional financial assets | --982.24M | --1.09B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Notes receivable and accounts receivable | 72.67%1.3B | 127.04%1.58B | 54.98%1.2B | 30.59%984.64M | 15.84%750.56M | -0.99%695.78M | 42.57%773.49M | 45.53%753.98M | --647.93M | 42.36%702.75M |
-Notes receivable | -28.58%55.31M | --104.17M | 56.06%112.62M | 104.22%98.86M | 44.64%77.44M | ---- | --72.16M | --48.41M | --53.54M | --109.31M |
-Accounts receivable | 84.32%1.24B | 112.07%1.48B | 54.87%1.09B | 25.54%885.78M | 13.25%673.12M | 17.24%695.78M | 29.26%701.32M | 36.19%705.57M | --594.39M | 20.22%593.44M |
Other receivables (including interest and dividends) | 1.48%26.92M | -24.59%20.82M | 1.92%25.68M | -22.00%27.22M | -26.54%26.52M | -2.77%27.61M | -29.07%25.2M | -2.51%34.9M | --36.1M | 32.66%28.4M |
-Other receivable | ---- | -24.59%20.82M | ---- | -22.00%27.22M | ---- | -2.77%27.61M | ---- | -2.51%34.9M | ---- | 32.66%28.4M |
Contractual assets | -7.34%1.13M | 24.47%1.72M | -63.38%1.63M | -56.27%1.48M | -65.22%1.22M | -60.54%1.39M | --4.46M | --3.39M | --3.5M | --3.51M |
Advance payment | 61.51%105.66M | 63.04%101.38M | -10.25%68.12M | -24.08%60.77M | 6.48%65.42M | 21.79%62.18M | -9.18%75.9M | -2.43%80.04M | --61.44M | -17.45%51.05M |
Inventories | -0.38%1.15B | -7.50%1.12B | -25.20%1.14B | -26.06%1.09B | -14.36%1.15B | -7.27%1.21B | 22.27%1.52B | 24.26%1.48B | --1.35B | 36.10%1.3B |
Other current assets | 13.22%261.81M | 41.31%323.01M | -13.97%181.76M | 16.74%223.92M | 54.92%231.25M | 47.76%228.58M | 108.77%211.28M | 86.98%191.82M | --149.28M | 50.47%154.7M |
Total current assets | 1.93%6.58B | -6.91%6.51B | -19.70%6.24B | -25.05%6.31B | -20.95%6.45B | -19.72%7B | -20.98%7.77B | 85.37%8.42B | --8.16B | 104.26%8.72B |
Non Current assets | ||||||||||
Other equity investment | -20.92%67.31M | -20.92%67.31M | 21.68%85.32M | 54.79%85.32M | 54.43%85.12M | 54.43%85.12M | 37.72%70.12M | 8.26%55.12M | --55.12M | 8.26%55.12M |
Other non-current financial assets | 17.19%70.24M | 75.88%70.24M | 78.33%71.33M | 78.33%71.33M | 49.84%59.94M | -0.16%39.94M | --40M | --40M | --40M | --40M |
Long term receivable account | 22.02%10.25M | 24.22%10.42M | --10.15M | --10.34M | --8.4M | --8.39M | ---- | ---- | ---- | ---- |
Fixed assets | ---- | 3.66%2.08B | ---- | 202.70%2.09B | ---- | 210.93%2B | ---- | 9.62%689.86M | ---- | 5.53%644.16M |
Fixed assets liquidation | ---- | -78.59%803.41K | ---- | --3.7M | ---- | --3.75M | ---- | ---- | ---- | ---- |
Constru in process | ---- | 28.80%438.52M | ---- | -66.37%385.92M | ---- | -54.71%340.48M | ---- | 1,167.68%1.15B | ---- | 1,180.86%751.73M |
Intangible assets | -15.85%534.92M | -15.01%560.33M | -12.07%606.25M | -9.70%631.74M | -5.32%635.67M | -4.14%659.28M | 0.93%689.48M | 16.72%699.59M | --671.36M | 5.86%687.75M |
Development expenditure | --97.26M | --64.7M | --37.03M | --17.44M | ---- | ---- | ---- | ---- | ---- | ---- |
Long deferred expense | -22.67%87.74M | 1.48%114.49M | 30.53%103.9M | 32.67%106.43M | 33.95%113.46M | 59.69%112.82M | 44.90%79.6M | 38.14%80.22M | --84.71M | 6.23%70.65M |
Deferred tax assets | 15.45%120.96M | 6.63%122.54M | 12.29%130.24M | -4.24%121.79M | -6.24%104.77M | 21.48%114.92M | 40.08%115.98M | 136.52%127.18M | --111.75M | 111.91%94.6M |
Usufruct assets | 161.53%211.49M | 136.96%222.56M | -17.74%78.22M | -19.97%79.87M | -11.78%80.87M | -6.52%93.92M | -10.01%95.09M | 6.96%99.8M | --91.67M | -3.13%100.48M |
Other non current assets | -57.62%36.78M | -47.06%47.22M | -52.87%33.32M | -27.95%43.82M | 82.73%86.78M | 93.94%89.19M | -9.84%70.71M | 35.23%60.82M | --47.49M | -49.08%45.99M |
Total non current assets | 4.35%3.74B | 6.79%3.8B | 16.61%3.7B | 21.36%3.65B | 40.14%3.59B | 42.27%3.56B | 66.60%3.18B | 84.78%3.01B | --2.56B | 49.28%2.5B |
Total assets | 2.79%10.32B | -2.29%10.31B | -9.16%9.94B | -12.83%9.97B | -6.37%10.04B | -5.89%10.56B | -6.75%10.94B | 85.21%11.43B | --10.72B | 88.76%11.22B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | ---- | ---- | ---- | ---- | 100.01%100.08M | 100.01%100.08M | --100.07M | --100.07M | --50.04M | 66.57%50.04M |
Notes payable and accounts payable | 59.18%290.81M | 83.00%394.76M | -17.24%293.82M | -39.54%218.59M | -47.33%182.69M | -53.09%215.72M | -23.06%355.02M | -31.28%361.54M | --346.86M | 32.41%459.87M |
-Notes payable | 11.11%55.16M | 43.62%82.73M | -2.30%72.82M | 29.08%43.73M | 66.02%49.65M | 61.10%57.6M | 163.55%74.54M | -44.09%33.88M | --29.9M | 165.89%35.76M |
-Accounts payable | 77.12%235.66M | 97.34%312.03M | -21.21%221M | -46.63%174.86M | -58.02%133.05M | -62.72%158.12M | -35.24%280.48M | -29.61%327.66M | --316.96M | 27.04%424.11M |
Contract liabilities | 5.27%177.13M | -0.27%164.69M | -13.61%148.83M | -42.57%124.78M | -32.64%168.26M | -41.79%165.13M | -34.74%172.29M | -38.24%217.3M | --249.77M | -36.23%283.69M |
Salaries payable | -5.34%227.4M | 0.65%238.58M | -13.55%135.02M | -11.47%144.64M | 64.76%240.22M | -14.52%237.03M | 9.79%156.19M | 7.75%163.38M | --145.79M | 31.34%277.29M |
Taxs payable | 7.02%140.62M | 9.51%166.4M | -7.16%149.2M | -16.37%139.66M | -11.24%131.39M | -6.76%151.95M | -78.17%160.71M | 1.82%166.99M | --148.03M | -2.47%162.96M |
Other payable (including interest and dividends) | 4.95%364.56M | 1.72%473.31M | 68.18%404.4M | -41.93%315.85M | 143.08%347.38M | 176.37%465.3M | 42.68%240.46M | 556.59%543.89M | --142.91M | -7.83%168.36M |
-Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --149.63M | ---- | ---- |
-Other payable | ---- | 1.72%473.31M | ---- | -19.89%315.85M | ---- | 176.37%465.3M | ---- | 375.96%394.26M | ---- | -7.83%168.36M |
Non current liabilities due within one year | 94.74%89.44M | 8.93%53.13M | 43.85%60.47M | 11.04%56.04M | 4.11%45.93M | 14.98%48.77M | -7.37%42.04M | 47.45%50.47M | --44.12M | 21.09%42.42M |
Other current liabilities | 7.03%101.14M | 2.39%104.2M | -13.12%86.94M | -38.86%86.04M | -31.34%94.49M | -35.36%101.76M | -64.88%100.07M | -51.98%140.72M | --137.63M | -38.81%157.43M |
Total current liabilities | 6.15%1.39B | 7.36%1.6B | -3.63%1.28B | -37.77%1.09B | 3.58%1.31B | -7.26%1.49B | -37.37%1.33B | 8.15%1.74B | --1.27B | -4.38%1.6B |
Current liabilities | ||||||||||
Long term account payable | ---- | ---- | ---- | 6.78%40.04M | ---- | 6.99%38.78M | ---- | --37.5M | ---- | 7.52%36.24M |
Long term salaries pay | --10.33M | --2.12M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Deferred tax liabilities | -28.40%1.53M | -28.24%1.53M | 143.27%2.19M | 135.90%2.14M | 185.43%2.13M | 143.23%2.13M | -33.38%902.15K | -57.47%907.93K | --746.26K | -82.13%875.11K |
Long term deferred income | 31.42%129.36M | 46.67%141.77M | 42.35%140.49M | 0.16%93.96M | 50.32%98.43M | 97.85%96.66M | 127.41%98.69M | 105.67%93.8M | --65.48M | -0.86%48.86M |
Lease liabilities | 283.79%192.87M | 225.40%195.68M | -40.55%42.48M | -32.32%46.75M | -25.36%50.25M | -22.60%60.13M | -15.24%71.46M | -14.91%69.07M | --67.33M | -15.99%77.69M |
Total non current liabilities | 205.71%1.19B | 108.54%828.1M | 64.49%672.26M | 67.65%672.09M | 128.56%389.52M | 142.63%397.1M | 148.19%408.69M | 144.62%400.88M | --170.43M | -15.27%163.67M |
Total liabilities | 51.88%2.58B | 28.70%2.42B | 12.41%1.95B | -18.07%1.76B | 18.42%1.7B | 6.63%1.88B | -23.99%1.74B | 20.73%2.15B | --1.44B | -5.50%1.77B |
Shareholders equity | ||||||||||
Paid-in capital | 0.21%416.52M | 0.21%416.52M | 0.00%415.64M | 0.00%415.64M | 0.31%415.64M | 0.31%415.64M | 0.61%415.64M | 11.79%415.64M | --414.33M | 11.44%414.33M |
Capital reserve funds | 0.74%8.85B | 0.70%8.84B | 0.64%8.84B | 0.05%8.78B | 0.51%8.78B | 0.55%8.78B | 0.97%8.78B | 61.43%8.78B | --8.74B | 60.05%8.73B |
Surplus reserve funds | 0.00%46.79M | 0.00%46.79M | 0.00%46.79M | 0.00%46.79M | 0.00%46.79M | 0.00%46.79M | 0.00%46.79M | 0.00%46.79M | --46.79M | 0.00%46.79M |
Retained profit | -80.49%-1.2B | -130.21%-1.06B | -1,688.32%-924.79M | -1,681.46%-759.66M | -554.10%-662.42M | -256.05%-461.44M | -117.76%-51.71M | 103.46%48.04M | --145.88M | 117.08%295.69M |
Less:Treasury stock | 32.07%349.99M | 192.39%349.99M | --349.99M | --300.01M | --265.01M | --119.7M | ---- | ---- | ---- | ---- |
Other composite income | -31.95%-21.07M | 89.48%-2.91M | -77.08%-40.07M | 69.74%-12.48M | 83.58%-15.97M | 63.94%-27.67M | 36.09%-22.63M | 64.20%-41.26M | ---97.23M | 44.14%-76.72M |
Shareholders equity without minority interests | -6.72%7.74B | -8.62%7.89B | -12.92%7.98B | -11.62%8.17B | -10.24%8.3B | -8.27%8.63B | -2.59%9.17B | 112.40%9.25B | --9.25B | 134.91%9.41B |
Minority interests | -114.82%-5.71M | -96.13%1.54M | -83.98%6.47M | -11.63%36.82M | -1.89%38.52M | 0.80%39.8M | -3.04%40.38M | -2.76%41.67M | --39.27M | -41.62%39.49M |
Total shareholder equity | -7.22%7.74B | -9.02%7.89B | -13.23%7.99B | -11.62%8.21B | -10.20%8.34B | -8.23%8.67B | -2.59%9.21B | 111.28%9.29B | --9.29B | 131.98%9.45B |
Total liabilityies and equity | 2.79%10.32B | -2.29%10.31B | -9.16%9.94B | -12.83%9.97B | -6.37%10.04B | -5.89%10.56B | -6.75%10.94B | 85.21%11.43B | --10.72B | 88.76%11.22B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
Auditor | -- | -- | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.